Abstract
Objectives
Medication-related osteonecrosis of the jaws (MRONJ) is an extremely therapy-resistant disease involving the jaws especially following bisphosphonate treatment. Bisphosphonates accumulate in bone in concentrations sufficient to be directly toxic to the oral epithelium. Current therapeutic options are inadequate for the prevention and treatment of MRONJ. The aim of this study was to investigate effects of ozone gas plasma therapy on wound healing in bisphosphonate-applied human fibroblasts.
Material and methods
Human primary gingival fibroblasts were cultured. Cytotoxic concentrations (IC50) of bisphosphonates (pamidronate (PAM), alendronate (ALN), and zoledronate (ZOL)) were determined by MTT test. A 60 μg/μl for 30 s of ozone gas plasma application was performed to all experimental culture flasks after drug treatment at 24-h intervals as 3 s/cm2. Genotoxic damages were evaluated by comet assay and wound healing was determined by in vitro scratch assay.
Results
PAM, ALN, and ZOL applications caused genotoxic damage on primary human gingival fibroblast DNA. Ozone gas plasma therapy significantly decreased the genotoxic damage (p < 0.05), and this application provided 25, 29, and 27% less genotoxic damage in order of ALN, PAM, and ZOL groups. Ozone gas plasma therapy significantly increased wound healing rates both in postsurgical 24th and 48th hours for all doses of experimental drug groups (p < 0.05).
Conclusion
The ozone gas plasma application decreased genotoxic damage effect of bisphosphonate usage while improved the wound closure rate on human gingival fibroblasts.
Clinical relevance
Ozone gas plasma therapy may be helpful in prevention of gingival healing delay in MRONJ pathogenesis especially when applied simultaneously with surgical intervention.
Similar content being viewed by others
References
Svejda B, Muschitz C, Gruber R, Brandtner C, Svejda C, Gasser RW, Santler G, Dimai HP (2016) Position paper on medication-related osteonecrosis of the jaw (MRONJ). Wien Med Wochenschr 166:68–74
Soydan SS, Araz K, Senel FV, Yurtcu E, Helvacioglu F, Dagdeviren A, Tekindal MA, Sahin F (2015) Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts. Hum Exp Toxicol 34:1073–1082
Ravosa MJ, Ning J, Liu Y, Stack MS (2011) Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491–498
Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2009) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14:35–41
Pabst AM, Ziebart T, Koch FP, Taylor KY, Al-Nawas B, Walter C (2012) The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes—in vitro study. Clin Oral Investig 16:87–93
Simon MJ, Niehoff P, Kimmig B, Wiltfang J, Açil Y (2010) Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Investig 14:51–58
Acil Y, Moller B, Niehoff P, Rachko K, Gassling V, Wiltfang J, Simon MJ (2012) The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Craniomaxillofac Surg 40:e229–e235
Cozin M, Pinker BM, Solemani K, Zuniga JM, Dadaian SC, Cremers S, Landesberg R, Raghavan S (2011) Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg 69:2564–2578
Nogales CG, Ferrari PH, Kantorovich EO, Lage-Marques J (2008) Ozone therapy in medicine and dentistry. J Contemp Dental Pract 9:75–84
Azarpazhooh A, Limeback H (2008) The application of ozone in dentistry: a systematic review of literature. J Dentist 36:104–116
Zimmermann D, Waltimo T, Filippi A (2012) Ozonized water in dental traumatology—a preliminary study on the treatment of avulsed teeth, in vitro. Ozone Sci Eng 34:484–488
Yurtcu E, İşeri Ö, Sahin F (2014) Genotoxic and cytotoxic effects of doxorubicin and silymarin on human hepatocellular carcinoma cells. Hum Exp Toxicol 33:1269–1276
Işeri OD, Sahin FI, Terzi YK, Yurtcu E, Erdem SR, Sarialioglu F (2014) beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration. Pharm Biol 52:1374–1381
Bocci V (2004) Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediat Inflamm 13:3–11
Domb WC (2014) Ozone therapy in dentistry: a brief review for physicians. Interv Neuroradiol 20:632–636
Erdemci F, Gunaydin Y, Sencimen M, Bassorgun I, Ozler M, Oter S, Gulses A, Gunal A, Sezgin S, Bayar GR, Dogan N, Gider IK (2014) Histomorphometric evaluation of the effect of systemic and topical ozone on alveolar bone healing following tooth extraction in rats. Int J Oral Maxillofac Surg 43:777–783
Steinhart H, Schulz S, Mutters R (1999) Evaluation of ozonated oxygen in an experimental animal model of osteomyelitis as a further treatment option for skull-base osteomyelitis. Eur Arch Otorhinolaryngol 256:153–157
Agrillo A, Filiaci F, Ramieri V, Riccardi E, Quarato D, Rinna C, Gennaro P, Cascino F, Mitro V, Ungari C (2012) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci 16:1741–1747
Agrillo A, Ungari C, Filiaci F, Priore P, Iannetti G (2007) Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 18:1071–1075
Petrucci MT, Gallucci C, Agrillo A, Mustazza MC, Foà R (2007) Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 92:1289–1290
Vescovi P, Merigo E, Meleti M, Manfredi M, Fornaini C, Nammour S, Mergoni G, Sarraj A, Bagan JV (2014) Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690. doi:10.1155/2014/107690
Ripamonti CI, Cislaghi E, Mariani L, Maniezzo M (2011) Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I–II study. Oral Oncol 47:185–190
Agrillo A, Sassano P, Rinna C, Priore P, Iannetti G (2007) Ozone therapy in extractive surgery on patients treated with bisphosphonates. J Craniofac Surg 18:1068–1070
Agrillo A, Petrucci MT, Tedaldi M, Mustazza MC, Marino SMF, Gallucci C, Iannetti G (2006) New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Craniofac Surg 17:1080–1083
Csonka C, Pataki T, Kovacs P, Müller SL, Schroeter ML, Tosaki A, Blasig IE (2000) Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic Biol Med 29:612–619
Clavo B, Catalá L, Pérez JL, Rodríguez V, Robaina F (2004) Ozone therapy on cerebral blood flow: a preliminary report. Evid Based Complement Alternat Med 1:315–319
Bocci V (1999) Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci 56:270–279
Menendez S, Falcon L, Simon DR, Landa N (2002) Efficacy of ozonized sunflower oil in the treatment of tinea pedis. Mycoses 45:329–332
Baysan A, Whiley RA, Lynch E (2000) Antimicrobial effect of a novel ozone generating device on micro-organisms associated with primary root carious lesions in vitro. Caries Res 34:498–501
Vannucchi AM, Ficarra G, Antonioli E, Bosi A (2005) Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 128:738
Alpan AL, Toker H, Ozer H (2016) Ozone therapy enhances osseous healing in diabetic rats with calvarial defect: a morphometric and immunohistochemical study. J Periodontol 87:982–989
Taşdemir Z, Alkan BA, Albayrak H (2016) The effects of ozone therapy on the early healing period of de-epithelialized gingival grafts: a randomized placebo-controlled clinical trial. J Periodontol 87:663–671
Al Habashneh R, Alsalman W, Khader Y (2015) Ozone as an adjunct to conventional nonsurgical therapy in chronic periodontitis: a randomized controlled clinical trial. J Periodontal Res 50:37–43
Marx RE, Sawatary Y, Fortin M, Broumand V (2005) Bisphosphonate induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
The work was financially supported by the Baskent University Institutional Review Board and Ethics Committee (Project No: D-DA 13/02).
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Akdeniz, S.S., Beyler, E., Korkmaz, Y. et al. The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells. Clin Oral Invest 22, 867–873 (2018). https://doi.org/10.1007/s00784-017-2163-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-017-2163-6